Tag: Wavelinq
Vascular access creation: EndoAVF keeps future options open, but is not...
Based on over four years of experience in a single centre, Robert Shahverdyan (Asklepios Klinik Barmbek, Hamburg, Germany) claims that endovascular arteriovenous fistula (endoAVF)...
The WavelinQ™ EndoAVF System takes an innovative approach in creating endovascular...
NOTE: This advertorial is ONLY available to watch in selected countries and geographies
This advertorial, sponsored by BD, is intended for readers in the...
BD announces enrolment in postmarket studies of the WavelinQ endoAVF system
BD announced today that enrolment has begun and the first patients have been treated in the postmarket surveillance study, CONNECT-AV.
CONNECT-AV is a prospective, single-arm,...
Ellipsys system offers greater patient eligibility and reduced time to dialysis,...
Two devices for creating minimally invasive dialysis access—the Ellipsys vascular access system (Avenu Medical) and the WavelinQ 4F system (BD)—demonstrated high rates of technical...
UK-first innovation could save lives of dialysis patients
Barts Health NHS Trust has performed a UK-first operation outside of trial setting that could reduce mortality and risks of infection in patients with...
LINC 2020: Positive new data for AV access interventions released
New arteriovenous (AV) access results were presented at the 2020 Leipzig Interventional Course (LINC; 28–31 January, Leipzig, Germany), including data on percutaneous AV fistula...
BD receives FDA 510(k) clearance of WavelinQ 4F endoAVF system
BD has announced the 510(k) clearance from the US Food and Drug Administration (FDA) for the WavelinQ 4F endoAVF system earlier this month. The endoAVF...
Comparing and contrasting surgically-created AVFs with those made by endovascular means
Nicholas Inston (Birmingham, UK) tells Vascular News at LINC 2019 about the exciting field of percutaneous arteriovenous fistula (AVF) creation, the main devices and...
